Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CRBP

Corbus Pharmaceuticals

$5.35

-0.6 (-10.08%)

15:08
05/11/18
05/11
15:08
05/11/18
15:08
Recommendations
Corbus Pharmaceuticals analyst commentary at Cantor Fitzgerald »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$6.40

0.15 (2.40%)

08:05
05/10/18
05/10
08:05
05/10/18
08:05
Earnings
Corbus Pharmaceuticals reports Q1 EPS (21c), consensus (14c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
CRBP

Corbus Pharmaceuticals

$6.85

-0.25 (-3.52%)

11:06
03/13/18
03/13
11:06
03/13/18
11:06
Recommendations
Corbus Pharmaceuticals analyst commentary at Cantor Fitzgerald »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$7.25

-0.15 (-2.03%)

08:02
03/02/18
03/02
08:02
03/02/18
08:02
Hot Stocks
Corbus Pharmaceuticals to discuss development programs at Cowen conference »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$7.10

-0.4 (-5.33%)

07:22
02/02/18
02/02
07:22
02/02/18
07:22
Recommendations
Corbus Pharmaceuticals analyst commentary at Cantor Fitzgerald »

Corbus selloff reflects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$9.25

0.35 (3.93%)

13:28
01/30/18
01/30
13:28
01/30/18
13:28
Periodicals
STAT's Feuerstein cautious on Corbus study success »

STAT's Adam…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

CRBP

Corbus Pharmaceuticals

$9.25

0.35 (3.93%)

10:25
01/30/18
01/30
10:25
01/30/18
10:25
Conference/Events
Corbus Pharmaceuticals to hold a pharmaceutical update conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

CRBP

Corbus Pharmaceuticals

$9.25

0.35 (3.93%)

08:44
01/30/18
01/30
08:44
01/30/18
08:44
Technical Analysis
Technical Take: Corbus Pharmaceuticals spikes higher in pre-market »

Price was last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

CRBP

Corbus Pharmaceuticals

$9.25

0.35 (3.93%)

07:21
01/30/18
01/30
07:21
01/30/18
07:21
Recommendations
Corbus Pharmaceuticals analyst commentary at Cantor Fitzgerald »

Cantor Fitzgerald…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

CRBP

Corbus Pharmaceuticals

$9.25

0.35 (3.93%)

07:15
01/30/18
01/30
07:15
01/30/18
07:15
Hot Stocks
Corbus Pharmaceuticals receives $25M development award for lenabasum study »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.